The Role of Neuroimaging Biomarker in Drug Discovery for Schizophrenia

Folia Pharmacologica Japonica - Japan
doi 10.1254/fpj.140.107
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Neuroimaging Biomarkers for Early Drug Development in Schizophrenia

Biological Psychiatry
Biological Psychiatry
2014English

Functional Brain Connectivity Phenotypes for Schizophrenia Drug Discovery

Journal of Psychopharmacology
MedicinePsychiatryMental HealthPharmacology
2015English

Role of Neuroimaging in Analgesic Drug Development

Drugs in R and D
Pharmacology
2008English

Neuroimaging Evidence for the Deficit Subtype of Schizophrenia

JAMA Psychiatry
MedicinePsychiatryMental Health
2013English

Role of Plants in Anticancer Drug Discovery

Phytochemistry Letters
BiochemistryPlant ScienceAgronomyCrop ScienceBiotechnology
2014English

Further Neuroimaging Evidence for the Deficit Subtype of Schizophrenia

JAMA Psychiatry
MedicinePsychiatryMental Health
2015English

Emerging Role of Electron Microscopy in Drug Discovery

Trends in Biochemical Sciences
BiochemistryMolecular Biology
2019English

The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery

Angewandte Chemie - International Edition
CatalysisChemistry
2014English

The Role of Ubiquitination in Tumorigenesis and Targeted Drug Discovery

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy